טורבה 80 - Torva 80
מינונים נוספים | |
---|---|
קבוצה פרמקולוגית (ATC4) | C10AA HMG CoA reductase inhibitors |
מרכיב פעיל (ATC5) |
|
צורת מתן | פומי - PER OS |
צורת מינון | טבליות מצופות, COATED TABLETS למניעת מינון יתר או הרעלה יש ליטול את התרופה בהתאם למינון המומלץ כפי שמופיע בעלון לצרכן |
התוויה | Torva is indicated as an adjunct to diet for reduction of elevated total cholesterol LDL- cholesterol apolipoprotein B and triglycerides and to increase HDL Cholesterol in patients with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types IIa and IIb of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate. Torva is also indicated to reduce total-C and LDL -C in patients with homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatment (e.g. LDL apheresis) or if such treatments are unavailable.Pediatric patients (10-17 years of age) : Torva is indicated as an adjunct to diet to reduce total -C LDL-C and apo B levels in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present: 1. LDL-C remains >or = 190 mg/dl or 2. LDL-C remains > or = 160 mg/dl and: there is a positive family history of premature cardiovascular disease or two or more other CVD risk factors are present in the pediatric patient.Prevention of cardiovascular and/or cerebrovascular event such as MI or stroke: as an adjunct to correction of other risk factors such as hypertension in patients with three or more additional risk factors or diabetes with one additional risk factor.In patients with clinically evident coronary heart disease Torva is indicated to:Reduce the risk of non-fatal myocardial infarction.Reduce the risk of fatal and non fatal stroke.Reduce the risk for revascularization procedures.Reduce the risk of hospitalization for CHF.Reduce the risk of angina. |
עלון לרופא והחמרות לעלון |
אין עלון לרופא |
עלון לצרכן |
---|
ערכים בוויקירפואה | ערכים קשורים בוויקירפואה |
---|---|
טורבה 80 במאגר משרד הבריאות |
חיפוש מאמרים | מאמרים ב-PubMed |
---|---|
מידע ברשת | RxList WebMD Drugs.com |
שם יצרן | UNIPHARM LTD, ISRAEL |
שם בעל הרישום | UNIPHARM LTD, ISRAEL |
רישיון | תאריך הגשה: 4/2019. רישיון מתאריך: |
תאריך עדכון אחרון | {{{תאריך עדכון}}} |